v3.25.4

Stockholder's Equity (Tables)

3 Months Ended

Dec. 31, 2025

Stockholder's Equity [Abstract]

Schedule of Stock Option Activity

A summary of option activity under the stock plans is presented below:

		Shares				Weighted- Average Exercise Price				Weighted- Average Remaining Contractual Term				Aggregate Intrinsic Value
Outstanding at September 30, 2025			18,100,000			$	1.83				8.21 years			$	5,386,000
Granted			-				-
Forfeited			-				-
Outstanding at December 31, 2025			18,100,000			$	1.83				7.76 years			$	-
Exercisable at December 31, 2025			11,316,667			$	1.90				7.53 years			$	-

Schedule of Warrants Outstanding

The following table summarizes the warrants outstanding at December 31, 2025:

		Exercise price				Number				Expiration Dates
July 2025 Offering Investors		$	1.32				6,818,182			July 17, 2030
July 2025 Offering Agent		$	1.65				272,727			July 17, 2030
July 2025 Prior Offering Agent		$	1.65				477,273			July 17, 2030
September 2025 Offering Investors		$	1.84				5,142,858			March 10, 2031
September 2025 Offering Agent		$	1.92				205,714			March 10, 2031
September 2025 Prior Offering Agent		$	2.1875				360,000			March 10, 2031
December 2025 Offering Investors		$	0.0001				15,229,358			None
December 2025 Offering Investors		$	1.09				16,513,762			February 28, 2031
December 2025 Placement Offering Agent		$	1.3625				1,155,963			December 8, 2030
December 2025 Prior Offering Agent		$	1.199				660,550			December 8, 2030
							46,836,387

Schedule of Common Stock Reserved for Future Issuances

A summary of common stock reserved for future issuances by the Company as of December 31, 2025 is as follows:

Stock plan options outstanding			18,100,000
Restricted stock awards			11,600,000
Stock plan shares available for future grants			15,300,000
Warrants outstanding			46,836,387
Total			91,836,387

X

- Definition

Tabular disclosure of the change in common stock outstanding.

+ References

No definition available.

+ Details

Name:	us-gaap_ScheduleOfCommonStockOutstandingRollForwardTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 718
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (c)(1)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (d)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Section 50
-Paragraph 2
-Subparagraph (e)
-SubTopic 10
-Topic 718
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480429/718-10-50-2

+ Details

Name:	us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section 50
-Paragraph 3
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147481112/505-10-50-3

+ Details

Name:	us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration